Apple, Roku, Estée Lauder Beat Earnings Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 hours ago
0mins
Should l Buy EL?
Source: CNBC
- Apple's Strong Earnings: Apple reported a fiscal second-quarter earnings of $2.01 per share and revenue of $111.18 billion, surpassing analyst expectations of $1.95 and $109.66 billion, although iPhone sales missed estimates for the third consecutive quarter, indicating increasing market competition pressures.
- Roku's Robust Growth: Roku's first-quarter revenue reached $1.25 billion, exceeding the expected $1.20 billion, with adjusted EBITDA of $148.4 million also above the forecast of $131.3 million, highlighting the company's ongoing growth potential in the streaming market.
- Estée Lauder's Better-Than-Expected Performance: Estée Lauder reported third-quarter earnings of $0.91 per share and revenue of $3.71 billion, both exceeding analyst estimates, despite announcing job cuts as part of its turnaround strategy, reflecting its adaptive measures in a changing market.
- Moderna's Improved Financials: Moderna posted a first-quarter loss of $3.40 per share, better than the anticipated loss of $4.45, with revenues of $389 million surpassing the $236.4 million estimate, indicating its sustained competitiveness in the vaccine market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EL
Wall Street analysts forecast EL stock price to rise
18 Analyst Rating
8 Buy
9 Hold
1 Sell
Moderate Buy
Current: 76.710
Low
70.00
Averages
106.76
High
130.00
Current: 76.710
Low
70.00
Averages
106.76
High
130.00
About EL
The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its products are sold in over 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty. It is a licensee for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, and mascaras, eyeshadows and eyeliners.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Release Date: Estée Lauder is set to announce its Q3 earnings on May 1st before market open, with consensus EPS estimate at $0.65 and revenue expected to reach $3.69 billion, indicating significant market interest in its financial performance.
- Historical Performance Review: Over the past two years, Estée Lauder has beaten EPS estimates 100% of the time and revenue estimates 75% of the time, demonstrating strong stability and market confidence in its financial results.
- Expectation Adjustments: In the last three months, EPS estimates have seen 0 upward revisions and 18 downward revisions, while revenue estimates have experienced 2 upward revisions and 14 downward revisions, reflecting a cautious market outlook on the company's future performance.
- Merger Negotiation Dynamics: Ongoing discussions regarding a potential merger between Estée Lauder and Puig brands have not yet resulted in any decisions, but such talks could influence investor expectations regarding the company's future growth prospects.
See More

- Apple's Strong Earnings: Apple Inc. (AAPL) reported Q2 revenue of $111.18 billion, exceeding the consensus of $109.66 billion, and forecasted Q3 revenue growth of 14% to 17%, significantly above the 9.1% estimate, which propelled the Dow Jones Industrial Average up over 4%.
- Software Stocks Surge: Atlassian (TEAM) posted Q3 revenue of $1.79 billion, surpassing the consensus of $1.69 billion, leading to a stock price increase of over 25%, which not only boosted the software sector's performance but also enhanced investor confidence in tech stocks.
- Oil Price Fluctuations: WTI crude oil prices fell more than 1% after Iran responded to the latest US amendments on the agreement, despite an early advance, indicating that inflation concerns may be easing, but geopolitical factors remain a potential risk for oil prices.
- Overall Market Performance: So far, 81% of the 303 S&P 500 companies that reported Q1 earnings have beaten estimates, with overall Q1 earnings projected to climb 12% year-over-year, suggesting that improving corporate profitability may continue to support stock market gains.
See More
- Annual Profit Forecast Increase: Estée Lauder raised its full-year adjusted profit forecast to $2.35 to $2.45 per share, significantly up from the previous range of $2.05 to $2.25, reflecting a positive outlook amid restructuring and strategic market adjustments.
- Expanded Layoff Plans: The company announced an increase in global job cuts to 9,000 to 10,000, up from a prior estimate of 7,000, aiming to save up to $1.2 billion annually, indicating a strategic shift in light of merger discussions.
- Sales Performance Exceeds Expectations: Quarterly sales reached $3.71 billion, surpassing analysts' expectations of $3.69 billion, with adjusted profit at $0.88 per share, also exceeding the anticipated $0.65, showcasing strong performance in the luxury market.
- Market Environment Impact: Despite sluggish U.S. consumer spending, Estée Lauder achieved sales growth in luxury markets like China and Europe, while anticipating a 2-percentage-point negative impact on future sales due to geopolitical tensions in the Middle East.
See More
- Significant Earnings Growth: Estée Lauder reported an adjusted EPS of $0.91 for Q3, a 40% year-over-year increase that exceeded expectations by $0.26, highlighting the company's robust performance in the beauty market.
- Sales Increase: Net sales rose by 5% year-over-year, with adjusted gross margin widening by 140 basis points to 76.4%, indicating ongoing improvements in profitability and market competitiveness.
- Strong Cash Flow: Free cash flow surged to $891 million, reflecting strong operational cash flows and well-timed capital expenditures, providing ample funding for future investments.
- Optimistic Outlook: The company raised its organic sales growth forecast for fiscal 2026 to approximately 3%, with adjusted operating margin expected between 10.7% and 11.0%, demonstrating confidence in future market conditions.
See More

- Company Performance: Estée Lauder shares increased by 5% following the announcement of its annual profit forecast.
- Market Reaction: The positive market response indicates investor confidence in the company's financial outlook.
See More
- Apple's Strong Earnings: Apple reported a fiscal second-quarter earnings of $2.01 per share and revenue of $111.18 billion, surpassing analyst expectations of $1.95 and $109.66 billion, although iPhone sales missed estimates for the third consecutive quarter, indicating increasing market competition pressures.
- Roku's Robust Growth: Roku's first-quarter revenue reached $1.25 billion, exceeding the expected $1.20 billion, with adjusted EBITDA of $148.4 million also above the forecast of $131.3 million, highlighting the company's ongoing growth potential in the streaming market.
- Estée Lauder's Better-Than-Expected Performance: Estée Lauder reported third-quarter earnings of $0.91 per share and revenue of $3.71 billion, both exceeding analyst estimates, despite announcing job cuts as part of its turnaround strategy, reflecting its adaptive measures in a changing market.
- Moderna's Improved Financials: Moderna posted a first-quarter loss of $3.40 per share, better than the anticipated loss of $4.45, with revenues of $389 million surpassing the $236.4 million estimate, indicating its sustained competitiveness in the vaccine market.
See More









